目的：系统评价乳癖消治疗乳腺增生症的有效性,为临床提供循证参考。方法：计算机检索中国期刊全文数据库、中国学位论文全文数据库、万方数据库、中文科技期刊数据库、Cochrane图书馆、Medline和Pub Med,收集乳癖消联合三苯氧胺（试验...目的：系统评价乳癖消治疗乳腺增生症的有效性,为临床提供循证参考。方法：计算机检索中国期刊全文数据库、中国学位论文全文数据库、万方数据库、中文科技期刊数据库、Cochrane图书馆、Medline和Pub Med,收集乳癖消联合三苯氧胺（试验组）对比单纯三苯氧胺（对照组）治疗乳腺增生症的随机对照试验（RCT）,提取资料并按照修改后的Jadad评分量表和Cochrane偏倚风险评估量表评价纳入研究质量,采用Rev Man 5.3统计软件进行Meta分析。结果：共纳入23项RCT,合计2926例患者。Meta分析结果显示,试验组患者临床疗效[OR=3.60,95%CI（2.86,4.53）,P〈0.00001]、孕酮P[MD=1.54,95%CI（0.71,2.37）,P=0.0003]显著高于对照组,胃肠道反应[OR=0.66,95%CI（0.47,0.92）,P=0.01]、月经异常发生情况[OR=0.27,95%CI（0.18,0.40）,P〈0.00001]、促黄体激素LH[MD=-0.98,95%CI（-1.84,-0.12）,P=0.02]、肿块大小[MD=-0.68,95%CI（-0.86,-0.49）,P〈0.00001]、疼痛分级[OR=0.10,95%CI（0.04,0.22）,P〈0.00001]显著低于对照组,差异均有统计学意义。血清雌激素E2[MD=-3.95,95%CI（-8.68,0.78）,P=0.10]比较,差异无统计学意义。结论：乳癖消联合三苯氧胺治疗乳腺增生症疗效较好,可以显著改善患者的治疗效果,调节患者内分泌系统,减轻患者的疼痛感以及控制不良反应发生率。展开更多
OBJECTIVE: To observe the inhibitory effect of the Chinese herbal compound Guizhu capsule(CGZC)on lung cancer and explore the possible mechanism underlying its actions by evaluating its effects on the expression of ph...OBJECTIVE: To observe the inhibitory effect of the Chinese herbal compound Guizhu capsule(CGZC)on lung cancer and explore the possible mechanism underlying its actions by evaluating its effects on the expression of phosphate and tension homology deleted on chromsome ten(PTEN) and murine double mimute 2(MDM2) in lung cancer model mice.METHODS: A mouse model of transplanted lung cancer was established by subcutaneous inoculation of cancer cells into the axillae of mice. Twenty-four hours later, the mice were weighed and randomly divided into the model control group, cisplatin group(DDP group), and high, moderate and low dosage CGZC groups, with ten mice in each group. The control mice received an equal volume of distilled water. DDP was intraperitoneally injected at 1 mg/kg in the DDP group, once a day for 3days. CGZC diluted with distilled water was admin-istered at 20 g/kg(10 times the clinical adult dosage) in the high-dose group, 10 g/kg(5 times the clinical adult dosage) in the moderate-dose group and 5 g/kg(2.5 times the clinical adult dosage) in the low-dose group once a day for 10 days. On the11 th day, the mice were weighed and killed. The tumor tissues were weighed and the tumor inhibition rate was calculated. PTEN and MDM2 protein expression were detected by immunohistochemical analysis of tumor tissues.RESULTS: The CGZC high-and moderate-dose groups showed a significant inhibitory effect on tumor growth(P < 0.05); there was no significant difference between the high dose group and the DDP group(P > 0.05). The CGZC high-dose group also showed enhanced expression of PTEN protein(P <0.01) and decreased expression of MDM2 protein(P < 0.01) in lung cancer cells of the mice. There was no significant difference between the high dose group and the DDP group.CONCLUSION: CGZC has a significant inhibitory effect on transplanted lung cancer in mice. The mechanism may involve reducing expression of PTEN and decreasing the expression of MDM2 in the lung cancer tissues of the mice.展开更多
文摘目的：系统评价乳癖消治疗乳腺增生症的有效性,为临床提供循证参考。方法：计算机检索中国期刊全文数据库、中国学位论文全文数据库、万方数据库、中文科技期刊数据库、Cochrane图书馆、Medline和Pub Med,收集乳癖消联合三苯氧胺（试验组）对比单纯三苯氧胺（对照组）治疗乳腺增生症的随机对照试验（RCT）,提取资料并按照修改后的Jadad评分量表和Cochrane偏倚风险评估量表评价纳入研究质量,采用Rev Man 5.3统计软件进行Meta分析。结果：共纳入23项RCT,合计2926例患者。Meta分析结果显示,试验组患者临床疗效[OR=3.60,95%CI（2.86,4.53）,P〈0.00001]、孕酮P[MD=1.54,95%CI（0.71,2.37）,P=0.0003]显著高于对照组,胃肠道反应[OR=0.66,95%CI（0.47,0.92）,P=0.01]、月经异常发生情况[OR=0.27,95%CI（0.18,0.40）,P〈0.00001]、促黄体激素LH[MD=-0.98,95%CI（-1.84,-0.12）,P=0.02]、肿块大小[MD=-0.68,95%CI（-0.86,-0.49）,P〈0.00001]、疼痛分级[OR=0.10,95%CI（0.04,0.22）,P〈0.00001]显著低于对照组,差异均有统计学意义。血清雌激素E2[MD=-3.95,95%CI（-8.68,0.78）,P=0.10]比较,差异无统计学意义。结论：乳癖消联合三苯氧胺治疗乳腺增生症疗效较好,可以显著改善患者的治疗效果,调节患者内分泌系统,减轻患者的疼痛感以及控制不良反应发生率。
基金Supported by Science and Technology Project of Guangdong Province(No.73062)the Guangzhou Municipal Science and Technology Project(No.2007Z3-E5091)
文摘OBJECTIVE: To observe the inhibitory effect of the Chinese herbal compound Guizhu capsule(CGZC)on lung cancer and explore the possible mechanism underlying its actions by evaluating its effects on the expression of phosphate and tension homology deleted on chromsome ten(PTEN) and murine double mimute 2(MDM2) in lung cancer model mice.METHODS: A mouse model of transplanted lung cancer was established by subcutaneous inoculation of cancer cells into the axillae of mice. Twenty-four hours later, the mice were weighed and randomly divided into the model control group, cisplatin group(DDP group), and high, moderate and low dosage CGZC groups, with ten mice in each group. The control mice received an equal volume of distilled water. DDP was intraperitoneally injected at 1 mg/kg in the DDP group, once a day for 3days. CGZC diluted with distilled water was admin-istered at 20 g/kg(10 times the clinical adult dosage) in the high-dose group, 10 g/kg(5 times the clinical adult dosage) in the moderate-dose group and 5 g/kg(2.5 times the clinical adult dosage) in the low-dose group once a day for 10 days. On the11 th day, the mice were weighed and killed. The tumor tissues were weighed and the tumor inhibition rate was calculated. PTEN and MDM2 protein expression were detected by immunohistochemical analysis of tumor tissues.RESULTS: The CGZC high-and moderate-dose groups showed a significant inhibitory effect on tumor growth(P < 0.05); there was no significant difference between the high dose group and the DDP group(P > 0.05). The CGZC high-dose group also showed enhanced expression of PTEN protein(P <0.01) and decreased expression of MDM2 protein(P < 0.01) in lung cancer cells of the mice. There was no significant difference between the high dose group and the DDP group.CONCLUSION: CGZC has a significant inhibitory effect on transplanted lung cancer in mice. The mechanism may involve reducing expression of PTEN and decreasing the expression of MDM2 in the lung cancer tissues of the mice.
